Humanized Mice Exhibit Increased Susceptibility to Staphylococcus aureus Pneumonia

Area of Science:

• Immunology
• Microbiology
• Pathogen Research

Background:

• Staphylococcus aureus, particularly USA300 methicillin-resistant strains (MRSA), is a significant human pathogen.
• This pathogen expresses human-specific toxins like Panton-Valentine leukocidin (PVL) and LukAB, contributing to its virulence.
• Understanding the role of these toxins in disease pathogenesis is crucial for developing effective treatments.

Purpose of the Study:

• To investigate the specific roles of PVL and LukAB toxins in Staphylococcus aureus pneumonia pathogenesis.
• To evaluate the utility of humanized mouse models for studying host-pathogen interactions.
• To assess the impact of human immune cells on the severity of MRSA infection.

Main Methods:

• Utilized nonobese diabetic (NOD)-scid IL2Rγnull (NSG) mice engrafted with a human hematopoietic system (humanized mice).
• Infected humanized mice with wild-type USA300 MRSA and a Δpvl mutant strain.
• Quantified bacterial load, inflammatory cell infiltration (macrophages), and cytokine expression (TNF, IL-6) in lung tissues.
• Administered anti-PVL antibody treatment to assess its therapeutic effect.

Main Results:

• Humanized mice exhibited increased severity of USA300 infection, confirming the model's utility.
• PVL expression significantly increased pulmonary infection severity (30-fold higher bacterial load) compared to the Δpvl mutant.
• Anti-PVL antibody treatment promoted bacterial clearance.
• Mice infected with the Δpvl mutant showed significantly higher numbers of airway macrophages and greater expression of human TNF and IL-6.

Conclusions:

• Panton-Valentine leukocidin (PVL) plays a critical role in the pathogenesis of Staphylococcus aureus pneumonia.
• Humanized mouse models are effective for dissecting the roles of human-specific toxins and immune responses.
• Targeting PVL may be a viable therapeutic strategy against MRSA infections.